This molecular defect explains why SMN1 deficiency causes SMA, while SMN2 copy number (typically 1–5 copies in humans) serves as the primary phenotypic modifier, with higher copy numbers generally correlating with milder disease manifestations. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.